...
首页> 外文期刊>Journal of cataract and refractive surgery >Bimanual microphacoemulsification and Acri.Smart intraocular lens implantation combined with vitreoretinal surgery.
【24h】

Bimanual microphacoemulsification and Acri.Smart intraocular lens implantation combined with vitreoretinal surgery.

机译:双手微晶状体乳化术和Acri.Smart人工晶状体植入术联合玻璃体视网膜手术。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To assess the efficacy and safety of bimanual microphacoemulsification combined with vitrectomy in eyes with clinically evident cataract and vitreoretinal pathology. SETTING: Institute of Ophthalmology of the University of Modena and Reggio Emilia, Modena, Italy. METHODS: This prospective case series comprised 19 consecutive patients with clinically significant cataract who were scheduled for vitrectomy. Bimanual microphacoemulsification was performed, and an Acri.Smart 46 S hydrophobic acrylic intraocular lens (IOL) with a 6.0 mm optic (Acri.Tec, Inc.) was implanted in the capsular bag. Immediately after, standard 3-port vitrectomy was performed. RESULTS: The prevailing vitreoretinal pathology was retinal detachment, with 1 case of macular pucker and 1 case of macular hole. In all cases, the IOL was implanted in the capsular bag. There were no intraoperative complications during the cataract surgery or vitrectomy. Follow-up 1, 15, 30, 90, and 180 days after surgery showed significant visual recovery in all cases. The mean endothelial loss was 10.05%+/-2.01% (SD). In 3 cases that had tamponade with heavy silicone oil, progressive posterior capsule opacification occurred 6 months after surgery. CONCLUSIONS: Bimanual microphacoemulsification combined with vitrectomy was effective and safe. The microincisions and 19-gauge instruments provided excellent chamber resistance that simplified surgical maneuvers in eyes that might have a distorted fundus reflection and increased zonular laxity. The Acri.Smart 46 S IOL, which can be injected through a 2.0 mm incision, provided good fundus visibility during vitrectomy and good maneuverability up to the extreme periphery without resulting in glare or distracting reflections for the surgeon.
机译:目的:评估在临床上明显的白内障和玻璃体视网膜病变的眼中,双手微晶状体乳化联合玻璃体切除术的有效性和安全性。地点:意大利摩德纳大学和雷焦艾米利亚大学眼科研究所。方法:该前瞻性病例系列包括19例计划进行玻璃体切除术的具有临床意义的白内障连续患者。进行了双向微超声乳化术,并将具有6.0毫米光学元件(Acri.Tec,Inc.)的Acri.Smart 46 S疏水性丙烯酸人工晶状体(IOL)植入了囊袋中。之后立即进行标准的三端口玻璃体切除术。结果:主要的玻璃体视网膜病理是视网膜脱离,黄斑皱1 1例,黄斑裂孔1例。在所有情况下,IOL均植入囊袋中。白内障手术或玻璃体切除术没有术中并发症。术后1、15、30、90和180天的随访显示,所有病例的视力均得到明显恢复。平均内皮损失为10.05%+ /-2.01%(SD)。在3例填塞有重硅油的患者中,术后6个月发生了进行性后囊混浊。结论双手微晶状体乳化联合玻璃体切除术是安全有效的。显微切口和19号仪器可提供出色的腔室阻力,简化了可能使眼底反射变形和小带松弛的眼睛的手术操作。 Acri.Smart 46 S IOL可以通过2.0毫米切口进行注射,在玻璃体切除术中提供了良好的眼底可见度,并且在极高的边缘周围都具有良好的机动性,而不会给外科医生造成眩光或分散注意力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号